{"id":16624,"date":"2024-11-26T18:50:18","date_gmt":"2024-11-26T18:50:18","guid":{"rendered":"https:\/\/riaabarkergillette.com\/pk\/?p=16624"},"modified":"2025-10-20T12:54:08","modified_gmt":"2025-10-20T12:54:08","slug":"riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry","status":"publish","type":"post","link":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/","title":{"rendered":"RIAA challenges denial of concessional\u00a0customs duty for pharma industry"},"content":{"rendered":"\n<p>We represent a global consumer healthcare and pharmaceutical industry leader in a complex customs duty dispute before the Sindh High Court. The case challenges the denial of concessionary customs duty rates on materials required to manufacture an over-the-counter medicine that is a household name.<\/p>\n\n\n\n<p>The dispute centres on the interpretation of a condition in the Fifth Schedule to the Customs Act, 1969, which allows concessionary rates for importing packaging and other raw materials for the manufacture of drugs registered under the <a href=\"https:\/\/pakistancode.gov.pk\/english\/UY2FqaJw1-apaUY2Fqa-bpuUY2Rq-sg-jjjjjjjjjjjjj\">Drugs Act, 1976<\/a>, subject to their &#8220;in-house use in the manufacture of specified pharmaceutical substances&#8221;. The Directorate General of Input Output Co-efficient Organisation (IOCO) rejected our client\u2019s application for quantitative entitlement enabling the import, arguing that the use of a toll manufacturer disqualifies it from availing concessionary rates.<\/p>\n\n\n\n<p>Our client\u2019s petition before the Sindh High Court challenges this rejection, arguing that the condition is satisfied even when our client uses a toll manufacturer, as it retains ownership of the materials and finished product throughout the process. The petition argues that the rejection contradicts the Supreme Court&#8217;s judgment in Commissioner Inland Revenue vs Messrs Ori Tech Oil (Pvt.) Limited (2019 SCMR 875), which held that &#8220;in-house consumption&#8221; for manufacturing includes toll manufacturing arrangements.<\/p>\n\n\n\n<p><a href=\"https:\/\/riaabarkergillette.com\/pk\/our-team\/mayhar-mustafa-kazi\/?memberName=Mayhar%20Mustafa%20Kazi\">Mayhar Kazi<\/a>, Partner at RIAA Barker Gillette and lead counsel in this litigation, said:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>&#8220;This case has significant implications for the pharmaceutical industry and the interpretation of concessionary customs duty provisions. It highlights the complex interplay between fiscal and regulatory regimes in the pharmaceutical sector. Our strategic legal representation aims to ensure the uninterrupted supply of essential medicines while asserting our client&#8217;s legal rights.&#8221;<\/em><\/p>\n<\/blockquote>\n\n\n\n<p>This petition follows an earlier one we filed to challenge the jurisdiction of the IOCO to determine entitlement to concessionary benefits and contest the <em>vires<\/em> of Rule 313B of the Customs Rules as inconsistent with the Customs Act&#8217;s adjudication procedure. The Sindh High Court restrained coercive action against our client pursuant to such demand without proper adjudication. We also represented the company before the Customs Appellate Tribunal in appeals against orders passed in adjudication proceedings concerning its entitlement to the concessionary rates.<\/p>\n\n\n\n<p>Our team on this matter is led by Pakistan Partner <a href=\"https:\/\/riaabarkergillette.com\/pk\/our-team\/mayhar-mustafa-kazi\/?memberName=Mayhar%20Mustafa%20Kazi\">Mayhar Kazi<\/a> and includes Associate Muhammad Turhan Khan.<\/p>\n\n\n\n<p><strong>For more information on our tax dispute practice, please contact <a href=\"https:\/\/riaabarkergillette.com\/pk\/our-team\/mayhar-mustafa-kazi\/?memberName=Mayhar%20Mustafa%20Kazi\">Mayhar Kazi<\/a>.<\/strong><\/p>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<p style=\"font-size:15px\"><em>This article is not legal advice; it provides information of general interest about current legal issues.<\/em><\/p>\n\n\n\n<hr class=\"wp-block-coblocks-dynamic-separator\" style=\"height:50px\"\/>\n\n\n\n<p>RIAA Barker Gillette is Pakistan\u2019s premier law firm, with an on-the-ground presence in four major cities in Pakistan: Karachi, Islamabad, Lahore,&nbsp;and Peshawar,&nbsp;and&nbsp;affiliated offices in Dubai (DIFC)&nbsp;and&nbsp;London. <\/p>\n\n\n\n<p>The firm practices in all areas of corporate, commercial&nbsp;and&nbsp;dispute resolution law.&nbsp;Leading international legal directories consistently recognize the firm as&nbsp;a&nbsp;top-tier law firm in Pakistan.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large coblocks-animate\" data-coblocks-animation=\"fadeIn\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"103\" src=\"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2023\/07\/Lex_Mundi_1-line_Member_Azure_RGB-1024x103.jpg\" alt=\"Lex Mundi Logo\" class=\"wp-image-15411\" srcset=\"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2023\/07\/Lex_Mundi_1-line_Member_Azure_RGB-1024x103.jpg 1024w, https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2023\/07\/Lex_Mundi_1-line_Member_Azure_RGB-300x30.jpg 300w, https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2023\/07\/Lex_Mundi_1-line_Member_Azure_RGB-768x77.jpg 768w, https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2023\/07\/Lex_Mundi_1-line_Member_Azure_RGB-1536x155.jpg 1536w, https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2023\/07\/Lex_Mundi_1-line_Member_Azure_RGB.jpg 1986w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>RIAA Barker Gillette&nbsp;is the exclusive member firm in Pakistan for <a href=\"https:\/\/riaabarkergillette.com\/pk\/lex-mundi\/\">Lex Mundi<\/a>, the world\u2019s leading network&nbsp;of independent law firms with in-depth experience in over 125 countries worldwide. &nbsp;<\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RIAA Barker Gillette represents leading multinational pharmaceutical company in a complex customs duty dispute over concessionary rates for imported materials used in toll manufacturing of a widely-known over-the-counter medicine.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","footnotes":""},"categories":[9],"tags":[13],"class_list":["post-16624","post","type-post","status-publish","format-standard","hentry","category-news-story","tag-dispute-resolution"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RIAA Challenges Denial of Pharma Customs Duty Concession - RIAA Barker Gillette PK<\/title>\n<meta name=\"description\" content=\"RIAA Barker Gillette PK defends a top pharmaceutical firm in a customs duty dispute over import concessions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RIAA Challenges Denial of Pharma Customs Duty Concession - RIAA Barker Gillette PK\" \/>\n<meta property=\"og:description\" content=\"RIAA Barker Gillette PK defends a top pharmaceutical firm in a customs duty dispute over import concessions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/\" \/>\n<meta property=\"og:site_name\" content=\"RIAA Barker Gillette\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-26T18:50:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-20T12:54:08+00:00\" \/>\n<meta name=\"author\" content=\"Penny Dewar\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Penny Dewar\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\\\/\"},\"author\":{\"name\":\"Penny Dewar\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#\\\/schema\\\/person\\\/d0e3d73d743e31ec07d49b93ad348a6c\"},\"headline\":\"RIAA challenges denial of concessional\u00a0customs duty for pharma industry\",\"datePublished\":\"2024-11-26T18:50:18+00:00\",\"dateModified\":\"2025-10-20T12:54:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\\\/\"},\"wordCount\":390,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#organization\"},\"keywords\":[\"Dispute Resolution\"],\"articleSection\":[\"news story\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\\\/\",\"url\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\\\/\",\"name\":\"RIAA Challenges Denial of Pharma Customs Duty Concession - RIAA Barker Gillette PK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#website\"},\"datePublished\":\"2024-11-26T18:50:18+00:00\",\"dateModified\":\"2025-10-20T12:54:08+00:00\",\"description\":\"RIAA Barker Gillette PK defends a top pharmaceutical firm in a customs duty dispute over import concessions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RIAA challenges denial of concessional\u00a0customs duty for pharma industry\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#website\",\"url\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/\",\"name\":\"RIAA Barker Gillette\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#organization\",\"name\":\"RIAA Barker Gillette\",\"url\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/assets\\\/uploads\\\/2025\\\/11\\\/eSignature_RBG_Logo.png\",\"contentUrl\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/assets\\\/uploads\\\/2025\\\/11\\\/eSignature_RBG_Logo.png\",\"width\":85,\"height\":72,\"caption\":\"RIAA Barker Gillette\"},\"image\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#\\\/schema\\\/person\\\/d0e3d73d743e31ec07d49b93ad348a6c\",\"name\":\"Penny Dewar\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7af8caf3286d9c213254476dc6d0343c68aab9cf11d72412a03b6076d648d88d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7af8caf3286d9c213254476dc6d0343c68aab9cf11d72412a03b6076d648d88d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7af8caf3286d9c213254476dc6d0343c68aab9cf11d72412a03b6076d648d88d?s=96&d=mm&r=g\",\"caption\":\"Penny Dewar\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RIAA Challenges Denial of Pharma Customs Duty Concession - RIAA Barker Gillette PK","description":"RIAA Barker Gillette PK defends a top pharmaceutical firm in a customs duty dispute over import concessions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/","og_locale":"en_US","og_type":"article","og_title":"RIAA Challenges Denial of Pharma Customs Duty Concession - RIAA Barker Gillette PK","og_description":"RIAA Barker Gillette PK defends a top pharmaceutical firm in a customs duty dispute over import concessions.","og_url":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/","og_site_name":"RIAA Barker Gillette","article_published_time":"2024-11-26T18:50:18+00:00","article_modified_time":"2025-10-20T12:54:08+00:00","author":"Penny Dewar","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Penny Dewar","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/#article","isPartOf":{"@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/"},"author":{"name":"Penny Dewar","@id":"https:\/\/riaabarkergillette.com\/pk\/#\/schema\/person\/d0e3d73d743e31ec07d49b93ad348a6c"},"headline":"RIAA challenges denial of concessional\u00a0customs duty for pharma industry","datePublished":"2024-11-26T18:50:18+00:00","dateModified":"2025-10-20T12:54:08+00:00","mainEntityOfPage":{"@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/"},"wordCount":390,"commentCount":0,"publisher":{"@id":"https:\/\/riaabarkergillette.com\/pk\/#organization"},"keywords":["Dispute Resolution"],"articleSection":["news story"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/","url":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/","name":"RIAA Challenges Denial of Pharma Customs Duty Concession - RIAA Barker Gillette PK","isPartOf":{"@id":"https:\/\/riaabarkergillette.com\/pk\/#website"},"datePublished":"2024-11-26T18:50:18+00:00","dateModified":"2025-10-20T12:54:08+00:00","description":"RIAA Barker Gillette PK defends a top pharmaceutical firm in a customs duty dispute over import concessions.","breadcrumb":{"@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-challenges-denial-of-concessional-customs-duty-for-pharma-industry\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/riaabarkergillette.com\/pk\/"},{"@type":"ListItem","position":2,"name":"RIAA challenges denial of concessional\u00a0customs duty for pharma industry"}]},{"@type":"WebSite","@id":"https:\/\/riaabarkergillette.com\/pk\/#website","url":"https:\/\/riaabarkergillette.com\/pk\/","name":"RIAA Barker Gillette","description":"","publisher":{"@id":"https:\/\/riaabarkergillette.com\/pk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/riaabarkergillette.com\/pk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/riaabarkergillette.com\/pk\/#organization","name":"RIAA Barker Gillette","url":"https:\/\/riaabarkergillette.com\/pk\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/riaabarkergillette.com\/pk\/#\/schema\/logo\/image\/","url":"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2025\/11\/eSignature_RBG_Logo.png","contentUrl":"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2025\/11\/eSignature_RBG_Logo.png","width":85,"height":72,"caption":"RIAA Barker Gillette"},"image":{"@id":"https:\/\/riaabarkergillette.com\/pk\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/riaabarkergillette.com\/pk\/#\/schema\/person\/d0e3d73d743e31ec07d49b93ad348a6c","name":"Penny Dewar","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7af8caf3286d9c213254476dc6d0343c68aab9cf11d72412a03b6076d648d88d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7af8caf3286d9c213254476dc6d0343c68aab9cf11d72412a03b6076d648d88d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7af8caf3286d9c213254476dc6d0343c68aab9cf11d72412a03b6076d648d88d?s=96&d=mm&r=g","caption":"Penny Dewar"}}]}},"_links":{"self":[{"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/posts\/16624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/comments?post=16624"}],"version-history":[{"count":3,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/posts\/16624\/revisions"}],"predecessor-version":[{"id":17421,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/posts\/16624\/revisions\/17421"}],"wp:attachment":[{"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/media?parent=16624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/categories?post=16624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/tags?post=16624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}